Arturo Molina - Jan 16, 2025 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Chief Medical Officer
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Arturo Molina, MD
Stock symbol
PTGX
Transactions as of
Jan 16, 2025
Transactions value $
$0
Form type
4
Date filed
1/17/2025, 05:47 PM
Previous filing
Jan 6, 2025
Next filing
Mar 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTGX Common Stock Sale $0 -388 -0.44% $0.00 87.1K Jan 16, 2025 Direct F1
transaction PTGX Common Stock Sale $0 -3.25K -3.73% $0.00 83.9K Jan 16, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.